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Stlmmltry 
The nucleocapsid (NC) of the rabies virus behaves as an exogenous superantigen (SAg) in humans. 
In the present report, we analyzed whether it is also a SAg in mice by studying the effect of 
NC on T  cell receptor (TCR) VB expression in BALB/c mice. Repeated injection of NC in 
newborn BALB/c mice led to a marked reduction by two- to sixfold of V36 expressing CD4 + 
T  cells in spleen and in peripheral blood. Decrease of V36-expressing CD3 + mature T  cells 
was also observed in thymus. Single NC injection in footpad resulted in a three- to sixfold expansion 
of V36 CD4 + T cells, but not of CD8 + T cells, in the draining lymph nodes of BALB/c mice. 
The intensity of the stimulation was dose dependent and was maximal 3 d after the NC injection. 
The donal deletion of T cells bearing a particular V3 demonstrates that NC is a SAg in mice. 
T  cells, especially CD4 + T  cells, are an essential factor in host resistance  to rabies virus and 
also in the pathophysiology of paralysis; thus, we postulate that a rabies virus component, which 
stimulates T  cells, such as a SAg, may increase virus immunopathogenicity. To evaluate this 
hypothesis, we compared the course of rabies in adult BALB/c  lacking V36, 7, 8.1, and 9 T 
cells and in normal BALB/c.  Immune-related paralysis was decreased in BALB/c missing the 
NC target VBT cells. Transfer of V36 but not of V38.1-3 T cells into recipient mice lacking 
V36, 7, 8.1, and 9 allowed the immune-related paralysis to evolve. Taken together, these results 
strongly support the hypothesis that T cells expressing rabies SAg-specific V36 T cells, are involved 
in the genesis  of the immunopathology that is characteristic  of paralytic rabies. 
S 
uperantigens (SAgs)  1 are defined by the capacity to stim- 
ulate a large fraction of T cells predominantly on the basis 
of the Vl3 elements of the TCR (1). Unlike conventional an- 
tigens, they do not require antigen processing and bind out- 
side the peptide binding groove by clamping the MHC class 
II and the TCR molecules (2, 3). The best studied SAgs are 
the bacterial enterotoxins produced by Staphylococcus  aureus, 
the most potent T cell activators known so far (4). SAgs are 
also produced by other bacteria, mycoplasma (4, 5), and have 
been found to be encoded by exogenous and endogenous 
mouse mammary tumor retroviruses (MMTVs and Mtvs, 
respectively) (6-8). Retroviruses are known to be potentially 
severe immunopathological agents. This fact has spurred the 
search for new superantigens of viral origin in humans. Al- 
though SAg-like properties have been suggested for HIV-1 
(3, 9) this remains controversial  (10). To date, the only viral 
1 Abbreviations  used in this payer:  LNC, lymph node cell; MMTV, mouse 
mammary tumor retrovirus; NC, nucleocapsid; SAg, superantigen; SEB, 
staphylococcal enterotoxin B. 
SAg described in humans is the rabies virus nucleocapsid (NC) 
and its major component, the N  protein (11). NC consists 
of a viral strand of RNA covered with the three rabies viral 
core proteins, N, NS,  and L. NC can bind to MHC class 
II molecules without processing and can stimulate in vitro 
Vfl8 human T  lymphocytes (11). 
When SAgs are encountered during T cell development, 
they induce a decrease of reactive T cells by clonal deletion 
or by anergy (12, 13, 14). Vfl-specific deletions occur in mouse 
pups due to the integration in the germ line of endogenous 
SAg encoded by Mtv provirus (15, 16) or due to infection 
by MMTVs present in the milk (17, 18). Injection of the ex- 
ogenous SAg staphylococcal enterotoxin B (SEB) into new- 
born animals also leads to clonal deletion (19). However, be- 
fore deletion, SAgs usually induce expansion of the target 
T cells bearing specific Vfl. This was the case for exogenous 
SAgs encoded by MMTV(SW) or for endogenous Mtv-8 and 
-9 SAgs (6, 20). Expansion or deletion of entire Vfl subsets 
by a SAg is likely to exert a dramatic effect on pathogenesis 
of infection and host defense mechanisms and therefore on 
the outcome of infection. It has been shown that clonal dele- 
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Volume 180  October 1994  1207-1215 tion ofV•14  T cells obtained in transgenic mice by the over- 
expression of a V/314-specific  MMTV,  MMTV-C3H,  pre- 
vents further MMTV-C3H infection (21). Similarly, deletion 
of V~s induced by the presence of an endogenous Mtv in 
BALB/c has a drastic effect on resistance to experimental in- 
fection by the exogenous MMTV specific for the same target 
V~ (22). Taken together, these results suggest that SAg-specific 
V~3s are crucial elements for the MMTV infection.  As an 
explanation,  it  had  been hypothesized  that  MMTV  SAg 
amplifies  MMTV infection because it  stimulates  the virus 
reservoirs, the B cells,  with the help of the CD4 + T  cells 
(6,  23,  24). 
Rabies virus infects almost all mammals including labora- 
tory mice to which rabies virus strains have been adapted. 
T  cells,  especially CD4 + T  cells,  are an essential factor in 
host resistance to rabies virus (25) and also in the appearance 
of paralysis  which is thought  to be an inopportune conse- 
quences of the immune response (26, 27). Since SAg stimu- 
lates T  cells,  it could be expected that  a rabies SAg could 
activate the immune process and thus exacerbate the patho- 
physiological sequelae.  An animal model is required to test 
this hypothesis. 
In this work, we tested whether the NC SAg properties, 
already established in vitro with human T cells, existed also 
in mice. To do this,  we analyzed whether NC can induce 
the expansion and the deletion of particular V~s in BALB/c 
mice. Then, we studied the role of NC-specific V~ T lym- 
phocytes in  the  development  of the  clinical  syndrome  of 
immune-related  paralysis. 
Materials  and Methods 
Rabies NC.  NC was purified from rabies virus-infected ham- 
ster (baby hamster kidney ceils clone SR [BSR]) ceil lysates through 
CsC1 gradients as previously described (28). Cell cultures and virus 
seed lots were found to be mycoplasma free by specific hybridiza- 
tion,  DNA staining and agarose isohtion techniques. 
Mice.  Three types of mice were used in these experiments: 
(a) female BALB/c (H-2 d, I-E +,  V~3,  5,  and  11 deleted) pur- 
chased fromJanvier (St-Berthevin, France); (b) congenic BALB/D2 
(H-2  d, I-E +, Mlsla: VB6, 7, 8.1, and 9 deleted) (29), a gift from 
Martine Brulay-Rosset (Villejuif, France); and (c) female BALB/c 
infected with MMTV(SW) obtained from IFFA-Credo (l'Arbresle, 
France). These BALB/c mice are known to delete V~6, 7, and 8.1  2 
as a consequence of infection by the milk-boru MMTV, MMTV  3 
(SW) (18). During experiments, MMTV carriers and MMTV non-  4 
infected animals were housed in separated isolators. 
Injections.  Baby mice,  born  from  BALB/c mothers  free of  5 
MMTV(SW), were used for the neonatal deletion analysis. New-  6 
born mice were inoculated i.p. each every other day after birth with  7 
50/zg of NC for a 2-wk period following a protocol previously  8.1,2 
described (19). Control animals were injected with RPMI 1640 
medium. To reduce variability, new-born mice from multiple litters  8.1,2,3 
were randomly  assigned to tither  sham-injected or NC-injected  9 
litters. Mice were injected i.p. with 1 mg of hydrocortisone 2 d  10 
before sacrifice to eliminate immature thymocytes (30). Two mice  11 
in each litter were sacrificed 4, 5, 6, 9, and 12wk afterbirth. These 
dates correspond respectively to 2--4, 6, and 10 wk after the last  14 
NC injection.  Spleen, thymus,  and blood were taken from each  17 
animal and double stained before being an,lyzed by cytofluorometry. 
To analyze peripheral stimulations  of T cells by NC, 8- to 11- 
wk-old female BALB/c, free of MMTV(SW), were injected with 
3 to 80/zg of NC in each footpad according to an already described 
protocol (18). Control mice were injected with CFA by the same 
route.  Popliteal lymph node cells (LNCs) were removed 3, 5, 9, 
and 12 d, disrupted and double stained for flow cytometry analysis. 
Staining and Flow Cytometric  Anali~is.  Splenocytes, thymocytes, 
and popliteal LNCs from both medium- and NC-injected animals 
were treated with buffered ammonium  chloride to lyse erythro- 
cytes and then washed twice in phosphate buffer saline containing 
Ca  z  §  2  + (PBS Ca  2  +/Mg  z  +).  Circulating  blood lymphocytes 
were obtained from blood of retro-orbital  sinus, purified through 
Ficoll-Hypaque and washed twice in PBS Ca  z+/Mg  2+. Lympho- 
cytes were incubated with one of the V~-specilic  biotinyhted mAbs 
(Table 1). PE-conjugated streptavidin was used as a second step in 
conjunction  with  FITC-conjugated  hamster  anti-CD3 +  mAb 
2Cll (31) or rat anti-CD4 + GK1.5 (gift from M. Pierres, Centre 
d'Immunologie,  Marseille Lumigny, France) or mouse anti-CD8 + 
JR4.5 (gift fromJ. Rolland, Institut Pasteur, Paris, France). Cells 
were analyzed in a FACScan  |  cytofluorometer (Becton Dickinson 
& Co., Mountain View, CA). Mature thymocytes and blast LNCs 
were gated by forward and side-scatter analysis. 
Infection of  Mice with Rabies Virus.  Mice were injected intramus- 
cularly (i.m.)  with  1  x  107 infectious  particles of rabies virus 
Pasteur Virus strain (PV4) in both hind legs. Signs of weakness 
and paralysis and death were recorded every day up to 16 d after 
the virus injection.  Weakness was determined by measuring  the 
animal's ability to support its body weight with its hind legs. Pa- 
ralysis was defined as a total loss of hind leg motility.  In the rare 
cases of death, death by rabies was verified by checking for the pres- 
ence of rabies virus in brains using immunofluorescence technique. 
Transfer of VB T Lymphocytes.  V~6 and VB8.1-3 T lympho- 
cytes were extracted from spleens of 8-wk-old male BALB/c by pan- 
ning using anti-V~6 and anti-V~8.1-3 mAbs (~hble 1). 14-wk-old 
male BALB/D2 were transfused by tail vein injection of 14  x  106 
V~6 or V~8.1-3 T splenocytes. Control mice were not transfused. 
Each group contained four animals. 1 h after ceil transfer, mice 
were infected i.m. with rabies virus as described above. 
Table  1.  VB-speci.[ic  Monoclonal Antibodies 
VB  Name  Species  Reference 
B20.6  Rat  39 
K  J25  Hamster  40 
KT4  Rat  41 
MR9-4  Mouse  42 
RR4-7  Rat  43 
TR310  Rat  44 
KJ16  Rat  45 
F23.1  Mouse,  C57L/J  46 
MR10-2  Mouse,  SWR  47 
B21.5  Rat  39 
RR3-15  Rat  48 
14.2  Rat  49 
KJ23a  Mouse,  SWR  1 
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using appropriate frequency  analyses including student's t-test and 
chi-square calculations. 
Results 
Neonatal Deletion in Newborn Mic~  To assess the SAg prop- 
erty of rabies NC in mice, we searched for donal deletions 
of T cells expressing particular V/~ after neonatal injection. 
Percentages ofT cells expressing V/~2 to 11, and 14 in thymus 
and spleen  of both control and NC-injected  animals were 
estimated by cytofluorometry,  fn thymus, 6-wk after birth, 
the V/~6 CD3 + T  cells from NC-injected mice showed a de- 
crease compared  to controls (Fig.  1, compare B and A).  In 
spleen,  5 wk after birth, the number of CD4 + T  cells ex- 
pressing VB6 drops almost completely in the NC-injected 
compared to normal mice (Fig. 1, compare D with C). Means 
of percentages  of T  cells  expressing  V/~2 to  11 and 14 are 
shown in Fig.  2.  In spleen,  (Fig.  2 A),  a significant  drop 
of V/J6 in NC-treated animals occurred  (t  --  5.48, degree 
of freedom [d.f] --  8, and p  =  0.0006) whereas the drop in 
V/~7  NC-treated  CD4 +  T  cells  was  not  significant.  In 
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Figure  1.  Cytofluorimetry analysis ofu  T ceils in spleen and thymus 
of NC-treated  and uontreated newborn BALB/c mice. Thymocytes  (A 
and B) and splenocytes (C and D) from both medium (A and C) and NC- 
injected (B and D) animals were double stained with biotinyhted V/~ 6 
specific mAb (Table 1) and in a second step, with PE-conjugated strep- 
tavidin and with either FITC-conjugated  anti-CD4 mAb in the case of 
splenocytes or FITC-conjugated anti-CD3 mAb for thymocytes. Cells were 
analyzed in a FACScan  |  flow cytometer. Results are presented as log of 
fluor-=c.ence. The data depicted here are representative of all mice evalu- 
ated:  the NC-injected  mice had fewer VB6 than the noninjected  mice. 
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Figure  2.  Neonatal deletion in spleen and thymus of BALB/c mice in- 
jected  with NC. Analysis of TCR by (A) CD4 + splenocytes and (B) 
CD3 + thymocytes of NC-inoculated (I) and control 6-wk-old mice (?'A). 
Splenocytes and thymocytes from both medium and NC-injected animals 
were double stained with one of the biotinyhted Vigspecific mAbs (Table 
1) and then double stained and analyzed as in Fig. 1. Values are means 
of percentages +/- SD obtained in 4-2 mice of two separate experiments. 
Percentages of  V/~17 correspond to background of the double Staining  tech- 
nique,  since Vf117 gene is not functional  in BALB/c  mice. 
thymus, (Fig.  2 B) the percentage  of V/36 was significantly 
reduced in NC-treated animals compared  to sham-injected 
animals (t  =  4.52, df =  5, p  -  0.0062) whereas the drop 
of V/32 and V/~7 CD3 + thymocytes was not significantly 
altered in comparison with normal littermates.  The percen- 
tages of the other V~/were not modified, although the total 
number of mature  thymocytes was slightly lower in NC- 
injected  animals  (60%) compared  to controls (80%) (Fig. 
1, compare A and B). In summary, these results demonstrated 
that  neonatal injections  of NC  induce deletions  of V/~6 
CD4 + T cells in spleen and deletion of V~6 CD3 + T cells 
in thymus. 
Kinetics of  Deletion in New~ann BALB/c Mic~  The kinetics 
of the NC-specific V/~6 deletion were studied in the thymus 12 
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Figure  3.  Kinetic of V•6  neonatal deletion in CD4 + splenocytes and 
circulating lymphocytes and in CD3 + thymocytes of BALB/c mice. Time 
course of V/36 percentages was followed 4-6, 9, and 11 weeks after birth 
in (,4) CD4 + splenocytes,  (B) circulating lymphocytes, and (C) CD3 + 
thymocytes of NC-injected mice (O) or control mice (*). Values are means 
+/-  SD of percentages obtained for 4-2 mice (SPLEEN  and THYMUS) 
or values are percentages of pooled circulating lymphocytes taken from 
four mice (BLOOD). 
1210  Rabies Virus Superantigen  in Mice and in the spleen. Percentages of V/36 CD4 + T  cells were 
determined  as above in  two NC-injected and  two control 
litters at 4, 6, 9, and 12 wk after birth. In spleens, as shown 
in Fig. 3 A, deletion of V/36 CD4 + T  cells was detectable 
and maximal  5 wk after birth.  Percentage of V/36  CD4 + 
was still reduced in 6-wk-old mice but returned to control 
level (i.e.,  ~9%)  thereafter.  The time course of VB6 dele- 
tion was also studied in circulating CD4 + T cells taken from 
the blood of four NC-injected offspring (Fig. 3 B). Deletion 
was already achieved 4 wk after birth but disappeared after 
6 wk. In thymus (Fig. 3 C), the time course study indicates 
that the VB6 CD3 + deletion was maximal at 6 wk. Return 
to normal V/36 levels seemed to be less rapid in thymus than 
in  the periphery. 
Selective Expansion of Vff6 and Vff7 Expressing T Cells in 
Adult BALB/c Mice by NC Inoculation.  To analyze whether 
NC preferentially expands particular V/3s, we used the local 
injection technique which leads to a very strong T cell prolifer- 
ation in the draining LNs. Adult BALB/c, 8-11-wk-old mice, 
free of exogenous MMTV(SW),  were given footpad injec- 
tions ofNC, CFA, or medium alone. 3 d after NC injection, 
the popliteal LNs of NC-injected mice increased in size about 
fivefold in comparison with LNs of naive,  medium-injected 
mice. This increase was also observed after CFA injection but 
not after injection of medium alone. Popliteal LNs from both 
legs of NC- or CFA-injected mice,  were removed and the 
percentages of CD4 + LNCs bearing V/32, 4, 6-8,  10, or 14 
were estimated by cytofluorometry. Analysis of the size and 
granulometry indicated that the LN population obtained from 
control animals is homogeneous and is exclusively composed 
of resting lymphocytes. In contrast,  activation with NC, in 
the test group, or CFA, in the control group, was character- 
ized by the appearance of a blast population.  Percentages of 
Vl3s obtained in CFA blasts were similar to those obtained 
in resting LNCs of naive mice (data not shown), indicating 
that  the VB repertoire is not modulated by a non-specific 
inflammatory process. As shown in Fig. 4,  the number of 
CD4 + blasts expressing V/36 increased significantly from 9.6 
+  1.7%  in CFA-injected to 25.4  _+  0.9%  in  NC-treated 
LNCs (t =  6.24, p <0.0001). The number of blasts expressing 
V/37 increased threefold from 4.6 _  0.25% to 12.5  _+ 0.6% 
(t  =  3.75, p  =  0.0017). In two separate experiments,  NC 
injection  led to  an  increase of V/36 of up to  62%  of the 
CD4 + blasts in four animals.  In these cases, percent of V/37 
T cells was not modified, suggesting the existence of a com- 
pensatory mechanism during the expansion of particular VBs 
(data not  shown). 
We demonstrated above that NC stimulates particular V/3 
expressing CD4 + T cells. To test the effect of NC on CD8 + 
T cells, percentages of V/32, 6-8, and 14 were estimated among 
CD8 + LNCs. No significant changes of these V/3s could be 
observed between control and NC-injected LNCs (data not 
shown). This indicates that NC, in contrast to bacterial SAgs, 
does not stimulate peripheral  mouse CD8 + T  cells. 
Kinetics  of  NC Vff-specific  Expansion  and Dose-Respons,~  Ki- 
netics of expansion  for V/~6 and VB7 CD4 + LNCs were 
followed 3, 5, and 10 d after the local injection of NC. The 
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Figure 4.  TCR V/3 repertoire of CD4 + T cells in popliteal LNs of 
adult mice 3 d after NC injection. LNCs from control and NC-injected 
8-11-wk-old BALB/c  mice were double stained and analyzed as described 
in Fig. 1. Blast CD4 § T cells were gated by forward and side-scatter anal- 
ysis. Percentages given in black bars for eight NC-injected and hatched 
bars for three CFA-injected mice are the means +/-  SD. 
expansion  of V/36  and  V/37  CD4 +  LNCs  was  transitory 
with a peak response 3 d after the injection (data not shown). 
The effect of different doses of NC was tested in BALB/c 
mice using increasing doses from 3 gg up to 80 #g per hind 
leg. It was found that injection of a minimal dose of 3 gg 
induced an increase of 11 to 17% in the V/36 CD4 + T cells 
3 d after treatment. A maximal increase of 33% was obtained 
with 30/,g of NC, whereas injection of doses higher than 
30 #g produced no further increases in the V/36 percentages: 
29%  with  50/zg and 25%  with  80 gg. 
Role of  V~6 T Lymphocytes  in Rabies Virus  Immunopathology. 
Inasmuch  as  VB6  and  possibly  V~/7  CD4 +  T  cells  are 
specific targets of NC,  we addressed the question whether 
these VBs may interfere with rabies virus immunopathology 
by comparing the magnitude of immune-related  disease in 
BALB/c mice expressing different levels of VB6 and VB7 T 
cells. Both exogenous MMTV, the MMTV(SW) and endog- 
enous Mtv,  the Mtv 7 or 44, cause V~6 and V~7 T  cells 
deletion in infected BALB/c.  In a first set of experiments, 
BALB/c infected by MMTV(SW) were used as a source of 
mice missing the NC-specific VET cells. Percentages of mice 
showing signs of rabies-specific immunopathology, consisting 
of weakness and paralysis of the hind limbs, were recorded 
in MMTV(SW)-infected  and in normal  BALB/c.  In both 
groups, hind leg weakness was detectable as early as 5 d after 
infection and paralysis  appeared between day 7 and 10 and 
remained unchanged thereafter.  At day 13, significantly fewer 
(p <0.05) V/36-deficient mice than normal BALB/c showed 
signs of disease (Fig.  5, top). To avoid possible interference 
between MMTV and rabies infections, a similar experiment 
was performed in BALB/D2 mice bearing an integrated Mtv 
provirus, and thus missing constitutively Vt36, 7, 8.1, and 
9 T cells. As shown in the middle of Fig. 5, the mice lacking 
these VBs were significantly (p <0.05) more resistant to ra- 
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Figure  5.  Impact of the percentages of Vfl6 T cells on the mouse sus- 
ceptibility to rabies immunopathology. (Top) Percent of paralyzed mice  I 
bearing Vfl6 T lymphocytes  (l?etLB/c) and in BALB/c  mice missing Vfl6  C~ 
as a consequence of MMTV(SW) infection (BALB/c  SW). (M/rid/e) Per-  ~  E 
cent of  paralyzed  mice  in BALB/c  and in congenic  BALB/D2  lacking Vfl6  d~) 
because of  the integration of  the provirus  Mr'v-7.9  and 14-wk-old  BALB/D2 
(9w and 14w, respectively) were tested. (Bottom) Percent paralyzed  mice  > 
in BALB/D2 transfused with either Vfl6 (BALB/D2 + Vb6) or V08.1-3 
(BALB/D2 + VbS) splenocytes  or nontransfused BALB/D2. Mice were 
infected in the hind limbs with rabies virus (1  x  107 PFU/mouse). Per- 
centages of paralyzed  mice were recorded 13 d after rabies virus injection. 
Each group of mice was composed of 12 mice with the exception of Vfl-  G 
reconstituted BALB/D2 groups which were composed of four. 
bies paralysis (22 or 0%) than normal BALB/c (75%), indi- 
cating that absence of NC-specific Vfl T cells protect mice 
against immune disorders. Age is an important co-factor in 
resistance to rabies morbidity in VB6-defident mice, since 
none of the 14-wk-old BALB/D2 developed signs of disease 
whereas 22% of 9-wk-old BALB/D2 became paralysed (Fig. 
5,  middle). 
To demonstrate the role of rabies SAg-target V~ T cells 
in rabies immunopathology, V/56 or V/38.1-3 T  cells were 
transfused into BALB/D2 mice which normally lack these 
cells. Etfidency ofVfl6 reconstitution was checked 1 wk after 
transfer by analyzing circulating CD3 + blood cells (Fig. 6). 
Range of Vfl6 CD3 + T  cells counts were as follows: Vfl6 
transfused mice: 2.5-5.6% (Fig. 6 E) nontransfused BALB/D2 
controls: 0.6-0.7% (Fig. 6 A) and BALB/c, control 9-11% 
(Fig. 6 G). In mice transfused with VB8 T cells, a few Vfl6 
T  cells, 1.7%,  were  detectable  indicating  that  <1% 
(1.7-0.7%) ofVfl6 T cells were co-transferred with the Vfl8 
T cells (Fig. 6 C). Reconstitution with Vfl8.1-3 T cells did 
not modify the percentage of circulating Vfl8 T cells, since 
the percent  of Vfl8 T  cells in VflS-reconstituted  mice was 
similar, (24-27% in Fig. 6/3) to the VB8 percentage in Vfl6- 
reconstituted mice (25-28%  in Fig.  6 F)  or in the non- 
reconstituted mice (28% in Fig. 6 B). It is noteworthy that 
the anti-VB8 mAb, F23-1, which reacts with all three subsets 
of  Vfl8 did not detect the wall-documented decrease  of VflS-1 
in BALB/D2 (28% of V88 are shown both in BALB/c and 
t~LB/D2).  This could be due to a better affinity of mAb 
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Figure  6.  Efficiency  of  V/56 T cells transfer in BALB/D2 mice. IL~cen- 
tages of V~6 and V~8 T cells in circulating CD3 § T cells were estimated 
by cytofluorometry  as described  in Fig. 1. (.4 and B) BALB/D2  mice  missing 
V~6 and V~8.1; (C and D) BALB/D2 mice transfused with V~8(1-3) 
T cells; (E and F) BALB/D2 transfused with Vfl6 T cells, and (G and 
/-/) normal BALB/c. Results shown in this figure are representative data 
for mouse of each group. 
F23-I for  the  V~8.2 and  V/38.3  than  for  the  V~8.1 subset. 
Alternatively  this  may  reflect  compensatory  mechanisms  which 
keep  constant  the  overall  percentage  of  V158  T cells.  Rabies 
immunopathology  was compared in the V~6,  the V~8- 
transfused  BALB/D2- and  in  nontransfused  BALB/D2 (Fig. 
5,  bottom).  All  of the V~6-reconstituted BALB/D2 mice 
showed signs of severe paralysis as early as day 5, whereas 
all four of the nonreconsdtuted BALB/D2 mice remained 
free of paralysis. Among the V~8-reconstituted mice, only 
one, the one with 1.7% ofV~6 T cells showed limb weak- 
ness which progressed to paralysis  by day 10 (1/4:25%).  Taken 
together these results demonstrate that rabies immunopatho- 
logy is dependent on the presence of V~6 T  cells. 
1212  Rabies Virus Superantigen in Mice Although the immunopathological sign of hind limb pa- 
ralysis is common in these mice, death is rare.  In contrast 
to what has been observed in BALB/D2 mice, where the PV4 
rabies virus is rarely fatal (3 out of 35 infected mice), it is 
noteworthy that all the VB6 reconstituted BALB/D2 mice 
died of rabies by day 18. 
Dhcuss/on 
Recognition of a SAg by an host is a two-step reaction: 
first, SAg triggers the expansion of certain TCR Vfl subsets 
and later on, the expanded T cells enter into an unresponsive 
state and then die. An encounter at birth with SAg leads to 
a loss of most T cells expressing the reactive TCR Vfls during 
maturation in thymus (15). Clonal deletion of some entire 
VB subsets is regarded as a perquisite for a SAg. By showing 
that NC deletes T cells bearing particular VBs in mice, we 
demonstrated that NC is a superantigen and we strength- 
ened the previous results obtained in vitro with human lym- 
phocytes where NC expands VB8 T  cells, binds to surface 
class II molecules, probably by the ct chain, and does not 
require processing (11). Taken together, these data lead to the 
conclusion that NC behaves as a SAg in both humans and 
mice and emphasize the point that viruses other than mouse 
retrovirus can also encode SAgs. 
Demonstration that NC is a SAg for the mouse provides 
an experimental means to further investigate the role of ra- 
bies SAg in vaccination and in host infection. In this paper, 
we focused our attention on the role of rabies SAg in rabies 
infection and more precisely in rabies immunopathology.  After 
rabies virus enters both sensory and motor nerve ending, it 
replicates in the neuronal cell bodies of the ganglia. Then, 
the virus invades the central nervous system. Rabies can re- 
sult in two forms of disease: the encephalitic disease and the 
paralytic (32). In contrast to the encephalitic form of rabies, 
the paralytic form of rabies is characterized by a rapid dear- 
ance of rabies virus and by an almost complete absence of 
lethal outcome. Limb paralysis results from a peripheral im- 
munopathological process which causes mononudear cells 
infiltration and destroys the sciatic nerve (32, 26).  Paralysis 
is not observed in immunosuppressed mice or in nude mice 
but is seen after T cell reconstitution, indicating that T cells 
play a crucial  role in the induction of rabies paralysis (26, 
32, 33). The mechanism of this process remains unknown. 
At least, it is not mediated by cytotoxic CD8 + T cells, since 
removal of CD8 + T cells does not protect against paralysis 
(27). We postulate that a component of the rabies virus which 
can stimulate T calls strongly, such as the NC SAg, may play 
a role in this process. Our data strongly support this hypoth- 
esis; we found that: (a) rabies immunopathology  was decreased 
in BALB/c missing the NC-specific Vfls; (b) transfer of NC 
main targets V/36 T  cells but not of VB8.1-3  T  cells into 
deficient mice reactivated rabies virus immune-related pathol- 
ogy; and that (c) susceptibility to paralysis increases with the 
number of Vfl6 T cells. The finding that some of 9-wk-old 
BALB/D2 with 1.2% of Vfl6, were paralyzed whereas the 
14-wk-old BALB/D2, with 0.6%  of VB6) remain free of 
symptoms suggests that the 9-wk-old BALB/D2 show an 
immunopathological response to rabies because of the pres- 
ence of a few remaining Vfl6 T cells (1.2%). In contrast the 
14-wk-old BALB/D were protected because traces of Vfl6 
(0.6%) were not sufficient to induce paralysis. Age depen- 
dence of the number of Vfl6 among BALB/D2 is consistent 
with the observation that complete deletion of Mtv targets 
V~s is progressively acquired and only occurs after 10 wk 
(34). Similarly, VflS-transferred BALB/D2 mice expressing 
1.7% of V/36 T cells were only partially paralyzed whereas 
all the mice expressing more than 2% of V~6 T cells were 
paralyzed.  Thus, the threshold of V/36 T  cells required for 
significant paralysis seems to be approximatively fixed around 
2%. Altogether, these results strongly support the hypoth- 
esis that T cells expressing rabies SAg-spedfic V~6 T cells, 
are involved in rabies virus immunopathology. 
We cannot rule out  that other Vfl play a  role in im- 
munopathology since the mice which are less susceptible to 
rabies immunopathology also miss the Vfl7 T cells in addi- 
tion to the Vfl6 T cells. These ceils were also expanded in 
the periphery after NC injection (Fig. 4), however their ex- 
pansion was less important than the Vfl6 T cells expansion. 
Moreover, the V~7 T cells were not significantly deleted after 
neonatal expansion (Fig.  2) suggesting that NC may have 
a better affinity for V/36 TCR than for V~7 TCR. The dis- 
crepancy between expansion and deletion of Vfl7 T calls by 
NC can be linked to the observation that expansion induced 
by superantigens, such as TSST-1, is not always followed by 
anergy and thus by deletion (35). 
Previous observations  that CD8 + T cells are not involved 
in rabies  immunopathology and  the present finding that 
CD8 + T cells are not specific targets of rabies SAg strongly 
support the hypothesis that SAg-related immunopathology 
is deserved  only by the V~6 CD4 + T  cells. 
Enhancement of rabies immunopathology  by NC may be 
obtained because  NC  triggers an efficient  Vfl6 CD4 + T 
cell-mediated immune response which destroys the infected 
neurons in the periphery. Neurons normally do not express 
MHC class II molecules. INF-3, is able to stimulate MHC 
class II production. It cannot be excluded that SAgs which 
are known to make T cells to release large amounts of cytokines 
(36, 37), could trigger MHC class II expression on neuronal 
cells which became suitable targets for cytotoxic T cells. Al- 
ternatively, destruction of neurons could be obtained indirectly 
by killer microglia cells with the help of antibodies, via the 
mechanism of anta~xxly-dependent  cell cytotaxidty, the ADCC. 
Evidence has been obtained in mice that NC stimulates the 
production of neutralizing antibodies directed against the rabies 
virus envelope protein (38) suggesting that rabies SAg can 
induce cognate T-B interactions. In this hypothesis, rabies 
SAg could enhance the antibody response and induce an 
antibody-rehted immunopathology. It is not yet dear whether 
this immune response is sufficient to rid the nervous system 
of rabies virus. In the case of rabies, the balance between the 
immune response and the virus infection seems to play a key 
role in the issue of the disease. Several reports have noted that 
infected individuals died of rabies despite a strong immune 
1213  I~on et al. response suggesting that, most of the time, the immune re- 
sponse is launched too late to be efficient. Delay in the estab- 
lishment of the immune response could explain the discrepancy 
observed between the issue of the transfer experiment, where 
BALB/D2 +  VB6 died, and the experiment where NC in- 
duces protection (38). In our reconstitution experiment, VB6- 
transfused mice died despite a strong paralysis, whereas after 
the injection of NC a few hours or days before virus, para- 
lyzed mice were protected (38). 
The  finding  that  NC  can  exacerbate  the  rabies  im- 
munopathology in mice raises the questions about a possible 
role for NC in producing the high incidence of neurological 
complications that follows vaccination in humans using ra- 
bies vaccines prepared in animal brain. Rabies infection can 
be prevented in humans exposed to rabid animals by prompt 
administration of rabies  vaccine.  In several countries, such 
as Brazil or India, economic reasons  necessitate  the use of 
rabies vaccines prepared from inactivated rabies-infected  an- 
imal brains despite the neurological complications. Multiple 
injections of this vaccine over a 2-wk period are required to 
trigger an efficient immune response. We found that, in con- 
trast to rabies vaccine prepared in tissue culture, the animal 
brain vaccine contains large amounts of NC (Montano-Hirose, 
J.  A., and M. Lafon, manuscript in preparation). 
More experiments are needed to establish  whether neu- 
ropathological vaccine disorders  may be linked to the pres- 
ence of NC in brain rabies vaccines and to understand the 
mechanisms that can allow protection to rabies infection. The 
answers to these questions, in addition giving new insights 
in the role of SAg in infection, will have considerable conse- 
quence for vaccine design. 
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